Catalent Pharma Solutions has signed a definitive agreement to sell its U.S. commercial packaging operations in Philadelphia, PA and Woodstock, IL to a company affiliated with Frazier Healthcare. The transaction, subject to closing conditions, is expected to close in the next few months.
 
The transaction does not involve Catalent’s Clinical Supply Services operations in Philadelphia, or the Blow-Fill-Seal business in Woodstock, and doesn’t involve any commercial packaging activity Catalent conducts outside North America.
 
Catalent plans to focus on growing its businesses in development solutions and advanced delivery technologies, clinical trial supplies, advanced blow/fill/seal aseptic delivery technology for respiratory, ophthalmic and other products, as well as integrated solutions for the development and supply of injectable biologics and complex pharmaceutical products.